| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0005 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |